AIM
ARNA

Alambic Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Alambic Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,300
Closed -$92K – 706
2017
Q1 		$92K Buy
6,300
+3,670
+140% +$54.4K 0.01% 608
2016
Q4 		$37K Sell
2,630
-10
-0.4% -$155 0.01% 559
2016
Q3 		$46K Buy
2,640
+1,490
+130% +$24.7K 0.01% 499
2016
Q2 		$20K Buy
+1,150
New +$20.6K 0.01% 529

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alambic Investment Management's ARNA Position: Q2 2017 in Review

Alambic Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 6,300 shares — an estimated $92K sold.

Alambic Investment Management first reported a position in ARNA in Q2 2016 and held it in 4 quarters. The position peaked at $92K in Q1 2017. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Alambic Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Alambic Investment Management sold 6,300 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $92K.
  • Alambic Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 4 quarters.
  • Alambic Investment Management's Arena Pharmaceuticals Inc position peaked at $92K in Q1 2017.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Alambic Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.